# Evolent Health, Inc.: filings

EVH · NYSE · CIK 1628908 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/evh.md) · [Financials](/companies/evh/financials.md) · [Filings](/companies/evh/filings.md) · [Insiders](/companies/evh/insiders.md)

## Reports and events: 233 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 371, 8-K 160, 3 41, 10-Q 34, SC 13G/A 32, 144 20, SC 13G 15, UPLOAD 15, CORRESP 14, 424B7 13, DEFA14A 12, 10-K 11, DEF 14A 11, SCHEDULE 13G/A 11, D 8, S-8 7, 8-K/A 6, SCHEDULE 13G 6, SC 13D/A 5, ARS 4, 3/A 3, DRS/A 3, DRSLTR 3, FWP 3, S-1/A 3, S-3ASR 3, 144/A 2, 5 2, EFFECT 2, PRE 14A 2, 10-K/A 1, 424B1 1, 424B2 1, 424B3 1, 424B5 1, 4/A 1, 8-A12B 1, CERTNYS 1, CT ORDER 1, DRS 1, S-1 1, S-1MEF 1, S-3 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 08:53 ET | [10-Q](/filings/0001628908-26-000086.md) | Quarterly report, period 2026-06-30 | 0001628908-26-000086 |
| 2026-08-06 | 07:03 ET | [8-K](/filings/0001628908-26-000084.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-26-000084 |
| 2026-06-04 | 16:05 ET | [8-K](/filings/0001628908-26-000037.md) | 5.07 Shareholder vote results | 0001628908-26-000037 |
| 2026-05-07 | 08:46 ET | [10-Q](/filings/0001628908-26-000033.md) | Quarterly report, period 2026-03-31 | 0001628908-26-000033 |
| 2026-05-07 | 07:05 ET | [8-K](/filings/0001628908-26-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-26-000031 |
| 2026-04-24 | 16:13 ET | [DEF 14A](/filings/0001193125-26-177267.md) | Proxy statement, period 2026-06-04 | 0001193125-26-177267 |
| 2026-02-25 | 18:16 ET | [10-K](/filings/0001628908-26-000015.md) | Annual report, period 2025-12-31 | 0001628908-26-000015 |
| 2026-02-24 | 16:12 ET | [8-K](/filings/0001628908-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-26-000014 |
| 2025-12-08 | 08:00 ET | [8-K](/filings/0001628908-25-000145.md) | 8.01 Other events | 0001628908-25-000145 |
| 2025-12-02 | 07:32 ET | [8-K](/filings/0001628908-25-000141.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001628908-25-000141 |
| 2025-11-07 | 17:47 ET | [10-Q](/filings/0001628908-25-000133.md) | Quarterly report, period 2025-09-30 | 0001628908-25-000133 |
| 2025-11-06 | 16:21 ET | [8-K](/filings/0001628908-25-000132.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628908-25-000132 |
| 2025-09-23 | 16:13 ET | [8-K](/filings/0001628908-25-000124.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-25-000124 |
| 2025-08-21 | 17:04 ET | [8-K](/filings/0001193125-25-185388.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-185388 |
| 2025-08-19 | 08:14 ET | [8-K](/filings/0001193125-25-183075.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-183075 |
| 2025-08-18 | 16:18 ET | [8-K](/filings/0001193125-25-182692.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-182692 |
| 2025-08-11 | 06:27 ET | [10-Q](/filings/0001628908-25-000116.md) | Quarterly report, period 2025-06-30 | 0001628908-25-000116 |
| 2025-08-07 | 16:15 ET | [8-K](/filings/0001628908-25-000112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-25-000112 |
| 2025-06-20 | 06:32 ET | [8-K](/filings/0001628908-25-000098.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-25-000098 |
| 2025-06-05 | 16:55 ET | [8-K](/filings/0001628908-25-000072.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628908-25-000072 |
| 2025-06-03 | 06:48 ET | [8-K](/filings/0001628908-25-000069.md) | 7.01 Regulation FD disclosure | 0001628908-25-000069 |
| 2025-05-09 | 17:54 ET | [10-Q](/filings/0001628908-25-000066.md) | Quarterly report, period 2025-03-31 | 0001628908-25-000066 |
| 2025-05-08 | 16:12 ET | [8-K](/filings/0001628908-25-000064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-25-000064 |
| 2025-04-25 | 16:07 ET | [DEF 14A](/filings/0001193125-25-096749.md) | Proxy statement, period 2025-06-05 | 0001193125-25-096749 |
| 2025-04-22 | 06:33 ET | [8-K](/filings/0001628908-25-000055.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-25-000055 |
| 2025-02-21 | 18:22 ET | [10-K](/filings/0001628908-25-000020.md) | Annual report, period 2024-12-31 | 0001628908-25-000020 |
| 2025-02-20 | 16:18 ET | [8-K](/filings/0001628908-25-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-25-000018 |
| 2025-02-04 | 07:01 ET | [8-K](/filings/0001628908-25-000010.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-25-000010 |
| 2025-01-30 | 16:20 ET | [8-K](/filings/0001628908-25-000008.md) | 2.03 New direct financial obligation | 0001628908-25-000008 |
| 2025-01-13 | 16:57 ET | [8-K](/filings/0001628908-25-000004.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-25-000004 |
| 2024-12-11 | 16:56 ET | [8-K](/filings/0001628908-24-000117.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628908-24-000117 |
| 2024-11-08 | 18:19 ET | [10-Q](/filings/0001628908-24-000114.md) | Quarterly report, period 2024-09-30 | 0001628908-24-000114 |
| 2024-11-07 | 16:14 ET | [8-K](/filings/0001628908-24-000112.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-24-000112 |
| 2024-08-09 | 17:59 ET | [10-Q](/filings/0001628908-24-000090.md) | Quarterly report, period 2024-06-30 | 0001628908-24-000090 |
| 2024-08-08 | 16:16 ET | [8-K](/filings/0001628908-24-000089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-24-000089 |
| 2024-06-11 | 16:08 ET | [8-K](/filings/0001628908-24-000080.md) | 5.07 Shareholder vote results | 0001628908-24-000080 |
| 2024-06-04 | 07:05 ET | [8-K](/filings/0001628908-24-000057.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-24-000057 |
| 2024-05-10 | 18:09 ET | [10-Q](/filings/0001628908-24-000053.md) | Quarterly report, period 2024-03-31 | 0001628908-24-000053 |
| 2024-05-09 | 16:23 ET | [8-K](/filings/0001628908-24-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-24-000051 |
| 2024-04-26 | 16:20 ET | [DEF 14A](/filings/0001193125-24-118116.md) | Proxy statement, period 2024-06-06 | 0001193125-24-118116 |
| 2024-02-23 | 18:09 ET | [10-K](/filings/0001628908-24-000017.md) | Annual report, period 2023-12-31 | 0001628908-24-000017 |
| 2024-02-22 | 16:18 ET | [8-K](/filings/0001628908-24-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-24-000015 |
| 2024-02-14 | 16:15 ET | [8-K](/filings/0001628908-24-000010.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-24-000010 |
| 2024-01-08 | 17:00 ET | [8-K](/filings/0001628908-24-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-24-000005 |
| 2023-12-11 | 18:16 ET | [8-K](/filings/0001628908-23-000192.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000192 |
| 2023-12-06 | 06:09 ET | [8-K](/filings/0001628908-23-000183.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000183 |
| 2023-12-05 | 07:02 ET | [8-K](/filings/0001628908-23-000180.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000180 |
| 2023-11-03 | 08:55 ET | [8-K](/filings/0001628908-23-000176.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000176 |
| 2023-11-03 | 20:09 ET | [8-K](/filings/0001628908-23-000169.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000169 |
| 2023-11-02 | 17:18 ET | [10-Q](/filings/0001628908-23-000165.md) | Quarterly report, period 2023-09-30 | 0001628908-23-000165 |

Page 1 of 5. [Older](/companies/evh/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.